Skip to main content

Table 1 Demographic and clinical features of study participants

From: The rapid detection of respiratory pathogens in critically ill children

Variable

Total

Suspected CAP

Suspected HAP/VAP

p-value

N = 100

N = 80

N = 20

Demographics

Age (years)—median (IQR)

1.2 (0.3–5.2)

1.1 (0.3–4.8)

2.8 (0.9–15.0)

0.072a

Sex (male)—n (%)

58

44 (55)

14 (70)

0.224b

Weight (kilograms)—median (IQR)

10.6 (5.3–19.7)

9.8 (5.0–18.5)

12.9 (9.0–41.2)

0.066a

Significant co-morbidity—n (%)

33

24 (30)

10 (50)

0.091b

PIM3 score—median (IQR)

3.2 (0.5–5.0)

2.0 (0.5–5.0)

3.6 (2.1–5.0)

0.099a

Primary diagnostic category—n (%)

Respiratory

62

55 (69)

7 (35)

0.005b

Neurological

11

9 (11)

2 (10)

0.873b

Cardiovascular

7

5 (6)

2 (10)

0.346b

Trauma

6

4 (5)

2 (10)

0.709b

Post-operative care

6

1 (1)

5 (25)

< 0.001b

Other

8

6 (8)

2 (10)

0.712b

Admission source—n (%)

Retrieval team

67

57 (71)

10 (50)

0.071b

Emergency department

16

14 (18)

2 (10)

0.670b

Paediatric ward

10

7 (9)

3 (15)

0.694b

Theatre and recovery

7

2 (3)

5 (25)

< 0.001b

Clinical factors at time of sampling

Observations—mean (SD)

    

Temperature (°C)

36.9 (1.1)

36.9 (1.2)

37.0 (0.7)

0.890c

Fraction of inspired oxygen (%)

44.1 (19.7)

43.2 (18.5)

47.6 (24.2)

0.450c

Mean airway pressure (cm H2O)

12.0 (3.3)

11.9 (3.2)

12.4 (3.8)

0.617c

Secretions—n (%)*

Absent/minimal

29

27 (34)

2 (10)

0.034b

Present non-purulent

56

41 (52)

15 (75)

0.063b

Present purulent

14

11 (14)

3 (15)

0.902b

Chest X-rayn (%)*

Diffuse/patchy infiltrate

29

25 (32)

4 (20)

0.307b

Localised infiltrate

29

22 (28)

7 (35)

0.394b

No infiltrate

25

22 (28)

3 (15)

0.237b

Other

16

10 (13)

6 (30)

0.060b

Haematology and biochemistry—median (IQR)

    

White cell count (109/L)

8.5 (5.8–14.0)

8.6 (5.8–14.7)

8.0 (5.8–11.1)

0.520a

Neutrophils (109/L)

4.7 (2.7–10.3)

5.0 (2.7–10.7)

4.3 (3.1–7.6)

0.597a

Lymphocytes (109/L)

2.1 (1.0–3.2)

2.1 (1.0–3.2)

2.3 (1.1–3.3)

0.856a

Platelets (109/L)

280 (183–413)

301 (217–423)

220 (112–259)

0.007a

C-reactive protein (mg/L)

28 (7–93)

26 (6–83)

58 (10–186)

0.210a

Outcomes

    

Days free of treatment at 28 days–mean (SD)

    

Antimicrobial therapy

16.8 (7.9)

21.1 (6.7)

13.6 (8.3)

0.002c

Mechanical ventilation

19.1 (7.2)

20.1 (6.5)

14.8 (8.6)

0.016c

Inotropes

26.1 (5.1)

26.2 (4.9)

25.6 (5.6)

0.640c

PICU admission

16.8 (7.9)

17.9 (7.6)

11.4 (7.6)

0.003c

Survival to hospital discharge—n (%)

94

77 (96)

17 (85)

0.058b

  1. CAP community acquired pneumonia; HAP hospital acquired pneumonia; IQR interquartile range; LRTI lower respiratory tract infection; PICU paediatric intensive care unit; SD standard deviation; VAP ventilator-associated pneumonia
  2. *Data missing for one patient in the medical record
  3. aMann–Whitney U test
  4. bChi-square test for independence
  5. cStudent’s t-test for equality of means, two-sided p, equal variance not assumed